JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.